---
trial_id: 262
discovery_date: 2022-03-29 21:28:28.020350
date: 2022-03-29 21:28:28.020350
title: "Prolonged-release oral Fampridine in Multiple Sclerosis: effects on clinical, neurophysiological and quantified gait analysis parameters.
A cross-over, double-blinded, placebo-controlled study."
summary: |
  <p>EudraCT Number: 2012-005076-34<br />Sponsor Protocol Number: BEL-FMP-12-10325<br />Sponsor Name: Cliniques Universitaires Saint-Luc, Neurologie<br />Start Date: 2013-01-03<br />Medical condition: Multiple Sclerosis<br />Disease: <br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005076-34/BE">BE</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-005076-34'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2012-005076-34<br />Sponsor Protocol Number: BEL-FMP-12-10325<br />Sponsor Name: Cliniques Universitaires Saint-Luc, Neurologie<br />Start Date: 2013-01-03<br />Medical condition: Multiple Sclerosis<br />Disease: <br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005076-34/BE">BE</a> (Completed)</p>